
- GMP
About
OXB is a viral vector CDMO serving cell and gene therapy developers from pre-clinical through commercial stages. It operates facilities in the UK, US, and France and supports clients worldwide with development, GMP manufacturing, analytics, quality, and regulatory services.
Services
Process development
Develops viral vector processes across upstream and downstream stages to support scale-up and GMP readiness.
GMP manufacturing
Manufactures viral vectors under GMP from clinical through commercial supply.
Analytical methods
Develops and performs analytical testing to support vector characterization, release, and regulatory filings.
Regulatory support
Supports IND, MAA, and other regulatory submissions through to commercial launch.
Quality services
Provides integrated quality oversight across development, manufacturing, testing, and supply.
AAV manufacturing
Offers AAV development and manufacturing using the inAAVate™ platform.
Lentiviral vector manufacturing
Offers lentiviral vector development and manufacturing using the LentiVector™ platform.
Adenovirus manufacturing
Provides custom adenovirus development, manufacturing, and tech transfer-in.
Tech transfer
Transfers client or external processes into OXB for scale-up or long-term manufacture.
Fill-finish
Provides fill-finish services integrated with vector manufacturing.
- Turnaround
- AAV to GMP manufacture in as little as 7 months · Lentiviral vectors to GMP manufacture in as little as 9 months · Can accelerate timeline to GMP manufacturing by up to nine months
Capabilities
- Assays and studies
- AAV · Lentivirus · Process development · Analytical development · Fill-finish · Potency · Purity · Safety · Analytical assays · Regulatory analytical qualification
- Scale and capacity
- 18 GMP suites across geographies · 200L · 500L · 1,000L · 2,000L · 500L scale · 1,000L scale · 500L AAV scale · 200L lentiviral scale
- Therapeutic areas
- Cell therapy · Gene therapy · In vivo gene therapies
Modalities and species
- Modalities
- Viral vector · Cell therapy
- Species and models
- Chimpanzee adenovirus (ChAdOx1) · Wild type AAVs
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: development, manufacturing and commercial supply
Company
- Type
- CDMO
- Founded
- 1995
- Size
- 501-1000 employees
Locations
- Address
- 1 Patriots Park Bedford MA 01730
- Sites
- Oxford, United Kingdom · Lyon, France · Strasbourg, France · Dublin, Ireland
- Serves
- UK, US, Europe, global
Public records
- Biocom California CRO directory
- AAV, CDMO, contract manufacturing, Lenti, Viral Vector source
Similar labs
Work here? Claim this listing